For your weekend reading, we bring you the week's most popular stories from Energy and Capital and our sister site, Wealth Daily…
Tensions Rise with Iran; Here's What Investors Should Do Now
Defense expert Jason Simpkins joins host Jason Freiert on a special episode of the Angel Research Podcast. Tensions between the U.S. and Iran are heating up. What does this mean for the stock market and in particular, defense stocks?
Time to Buy? We May Have Just Hit the Bottom
They say March comes in like a lion, but this year it's seemed more like a wrecking ball. Stocks have been smashed almost entirely across the board, with even formerly hot sectors suffering.
Crisis Breeds Opportunity: The Must-Buy Oil Stocks Right Now (Not Exxon!)
We're entering a new phase of the Third Gulf War — and no, this isn't the end of the fighting.
What Triggered a Worldwide Revolt Against the Dollar?
A global shift away from the U.S. dollar is gaining momentum. Countries are increasing gold reserves, exploring non-dollar trade, and repositioning their balance sheets. This is "MoneyQuake" — the worldwide revolt against an 80-year monetary regime that can no longer support its own weight. And four tiny gold plays could surge 13,000% as the dollar era ends by design.
Air Taxis Are Taking Flight — Along With These Stocks
The FAA just approved eight pilot programs that will allow a handful of companies — including this one — to start widespread testing as early as this summer.
Gold's Worst Week Since 1983... What Comes Next?
Did Poland just break the gold market? For nearly a decade, Poland's central bank couldn't buy gold fast enough. Starting with just 103 tons in 2018, they aggressively stacked reserves to 550 tons.
Buffett and Gates Competing for the Same Energy Source
Warren Buffett and Bill Gates are pouring capital into a fast-emerging energy sector often described as tapping heat from deep beneath the earth's surface. It's a 100% clean, renewable, and reliable power source that's more powerful than the surface of the sun. And there's one little-known U.S.-listed stock that's set to play a leading role in this revolution and rally up to a breathtaking 59x in the coming months and years.
Gold Is Only as Valuable as Your Ability to Access It
In the vaults beneath London — thousands of miles from Caracas — sits billions of dollars' worth of Venezuelan gold. Gold that belongs to Venezuela. Gold they cannot access.
The Alaskan Road Nobody Wanted (Until China Reminded Us Why)
For years, environmental groups fought a 211-mile industrial road through northern Alaska. Once completed, the Ambler Road would cut through remote wilderness to reach one of the world's richest undeveloped copper deposits.
Trump's $21,307 Payout... Are You Eligible?
What if I told you your next tax bill could be $0? And instead of paying the government, you could start receiving massive dividend checks from them instead? Well, Trump just signed an executive order creating America's first-ever National Investment Fund — a system designed to replace income taxes while sending direct payments to everyday Americans. And a small group of early investors have already found a way to start collecting payouts as high as $21,307. But the window to claim your stake is closing fast.
Until next time,
Keith Kohl
Check us out on YouTube!
A true insider in the technology and energy markets, Keith's research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing's Energy Investor and Technology and Opportunity.
For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.
Keith's keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith's Topline Trader advisory newsletter.
Tidak ada komentar:
Posting Komentar